Da An Gene Co Ltd of Sun Yat-Sen University - Asset Resilience Ratio
Da An Gene Co Ltd of Sun Yat-Sen University (002030) has an Asset Resilience Ratio of 7.08% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Da An Gene Co Ltd of Sun Yat-Sen Univers to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how Da An Gene Co Ltd of Sun Yat-Sen University's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Da An Gene Co Ltd of Sun Yat-Sen Univers's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Da An Gene Co Ltd of Sun Yat-Sen University's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Da An Gene Co Ltd of Sun Yat-Sen Univers (002030) investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥590.00 Million | 7.08% |
| Total Liquid Assets | CN¥590.00 Million | 7.08% |
Asset Resilience Insights
- Limited Liquidity: Da An Gene Co Ltd of Sun Yat-Sen University maintains only 7.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Da An Gene Co Ltd of Sun Yat-Sen University Industry Peers by Asset Resilience Ratio
Compare Da An Gene Co Ltd of Sun Yat-Sen University's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
Biotechnology | 63.98% |
|
Tango Therapeutics Inc
NASDAQ:TNGX |
Biotechnology | 62.24% |
|
Damora Therapeutics, Inc.
NASDAQ:DMRA |
Biotechnology | 0.00% |
|
Wecome Pharmaceutical Co Ltd
SHE:300878 |
Biotechnology | 0.67% |
|
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
Biotechnology | 86.66% |
|
Relmada Therapeutics Inc
NASDAQ:RLMD |
Biotechnology | 95.25% |
|
MediWound Ltd
F:M8W |
Biotechnology | 56.04% |
Annual Asset Resilience Ratio for Da An Gene Co Ltd of Sun Yat-Sen University (2015–2025)
The table below shows the annual Asset Resilience Ratio data for Da An Gene Co Ltd of Sun Yat-Sen University.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.98% | CN¥593.89 Million ≈ $86.91 Million |
CN¥8.51 Billion ≈ $1.25 Billion |
+6.32pp |
| 2024-12-31 | 0.66% | CN¥63.00 Million ≈ $9.22 Million |
CN¥9.58 Billion ≈ $1.40 Billion |
-12.05pp |
| 2023-12-31 | 12.71% | CN¥1.40 Billion ≈ $204.90 Million |
CN¥11.02 Billion ≈ $1.61 Billion |
+9.45pp |
| 2022-12-31 | 3.26% | CN¥480.90 Million ≈ $70.37 Million |
CN¥14.76 Billion ≈ $2.16 Billion |
-0.42pp |
| 2021-12-31 | 3.68% | CN¥380.01 Million ≈ $55.61 Million |
CN¥10.34 Billion ≈ $1.51 Billion |
-9.58pp |
| 2020-12-31 | 13.25% | CN¥888.00 Million ≈ $129.94 Million |
CN¥6.70 Billion ≈ $980.42 Million |
+12.12pp |
| 2019-12-31 | 1.13% | CN¥40.24 Million ≈ $5.89 Million |
CN¥3.56 Billion ≈ $521.18 Million |
-22.70pp |
| 2018-12-31 | 23.83% | CN¥873.04 Million ≈ $127.75 Million |
CN¥3.66 Billion ≈ $536.06 Million |
+25.80pp |
| 2017-12-31 | -1.97% | CN¥-91.30 Million ≈ $-13.36 Million |
CN¥4.64 Billion ≈ $679.24 Million |
-2.18pp |
| 2016-12-31 | 0.22% | CN¥9.00 Million ≈ $1.32 Million |
CN¥4.14 Billion ≈ $605.76 Million |
-1.22pp |
| 2015-12-31 | 1.43% | CN¥43.60 Million ≈ $6.38 Million |
CN¥3.04 Billion ≈ $445.10 Million |
-- |
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers PCR testing kits, including hepatitis virus, human papillomavirus (HPV), sexually transmitted infections … Read more